Announced
Completed
Syncona led a £20m series A funding round in Kesmalea.
Synopsis
Syncona, a British closed-ended investment trust, led a £20m series A funding round in Kesmalea, a small molecule drug discovery company.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.